Cox James L has filed 9 insider transactions across 3 companies since January 2023.
Most recent transaction: a grant/award of 123000 shares of Lucid Diagnostics Inc. ($LUCD) on February 20, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 20, 2026 | Lucid Diagnostics Inc. | $LUCD | Cox James L | Director | A | Common Stock | 123000 | $0.00 | 405,120.0000 | 137,683,002 | 43.60% | 0.09% |
| March 20, 2025 | Adagio Medical Holdings, Inc. | $ADGM | Cox James L | Not found | A | Non-qualified stock option (right to buy) | 364000 | $0.00 | 364,000.0000 | 14,772,692 | 9999.99% | 2.46% |
| March 20, 2025 | Adagio Medical Holdings, Inc. | $ADGM | Cox James L | Not found | A | Non-qualified stock option (right to buy) | 90000 | $0.00 | 90,000.0000 | 14,772,692 | 9999.99% | 0.61% |
| Feb. 20, 2025 | Lucid Diagnostics Inc. | $LUCD | Cox James L | Director | A | Common Stock | 112800 | $0.00 | 282,120.0000 | 66,969,390 | 66.62% | 0.17% |
| July 31, 2024 | Adagio Medical Holdings, Inc. | $ADGM | Cox James L | Not found | J | Common Stock | 36698 | $0.00 | 36,698.0000 | 987,810 | 9999.99% | 3.72% |
| Feb. 22, 2024 | PAVmed Inc. | $PAVM | Cox James L | Director | A | Common stock | 65000 | $0.00 | 65,000.0000 | 7,231,546 | 9999.99% | 0.90% |
| Feb. 22, 2024 | Lucid Diagnostics Inc. | $LUCD | Cox James L | Director | A | Employee stock option (right to buy) | 150000 | $0.00 | 150,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2023 | Lucid Diagnostics Inc. | $LUCD | Cox James L | Director | A | Employee stock option (right to buy) | 175000 | $0.00 | 175,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 30, 2023 | PAVmed Inc. | $PAVM | Cox James L | Director | A | Employee stock option (right to buy) | 450000 | $0.00 | 450,000.0000 | 0 | 9999.99% | 0.00% |